Diclofenac/tolperisone controlled release

Drug Profile

Diclofenac/tolperisone controlled release

Alternative Names: Diclofenac SR/tolperisone SR; Diclofenac/tolperisone sustained release; Tolperisone SR/diclofenac SR; Tolperisone/diclofenac controlled release; Tolperisone/diclofenac sustained release

Latest Information Update: 21 Apr 2015

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Inventia Healthcare
  • Class Analgesics; Antirheumatics; Antiseptics; Antispasmodics; Muscle relaxants; Nonsteroidal anti-inflammatories; Phenylacetates; Propiophenones; Pyridines; Small molecules
  • Mechanism of Action Cyclooxygenase inhibitors; Neuromuscular blocking agents
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • No development reported Acute pain

Most Recent Events

  • 21 Apr 2015 No recent reports of development identified - Phase-III for Acute pain in India (PO)
  • 27 Jan 2012 Inventia Healthcare completes a phase III trial in Acute pain (low back pain) in India (CTRI2011-10-002074)
  • 20 Oct 2011 Phase-III clinical trials in Acute pain in India (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top